abagovomab 42
abciximab 35
abituzumab 31
abrilumab 27
actoxumab 30
adalimumab 17
aducanumab 18
afasevikumab 21
alacizumab_pegol 12
alemtuzumab 42
alirocumab 26
amatuximab 53
andecaliximab 35
anifrolumab 28
anrukinzumab 19
aprutumab 20
aprutumab_ixadotin 20
arcitumomab 26
ascrinvacumab 21
atezolizumab 16
atinumab 24
avelumab 21
basiliximab 51
bavituximab 42
begelomab 38
benralizumab 39
bevacizumab_beta 24
bezlotoxumab 30
bimagrumab 28
bleselumab 32
blinatumomab 49
blosozumab 35
bococizumab 29
brazikumab 20
brentuximab_vedotin 45
briakinumab 21
brodalumab 23
brolucizumab 30
brontictuzumab 37
burosumab 29
cabiralizumab 38
camrelizumab 15
canakinumab 25
cantuzumab_ravtansin 54
carlumab 27
carotuximab 29
cergutuzumab_amunaleukin2 33
cergutuzumab_amunaleukin 33
certolizumab_pegol 27
cetiximab 50
citatuzumab_bogatox 32
cixutumumab 43
clivatuzumab_tetraxetan 28
codrituzumab 39
conatumumab 27
concizumab 32
crenezumab 24
crizanlizumab 35
crotedumab 25
dacetuzumab 25
daclizumab 23
dalotuzumab 45
dapirolizumab_pegol 27
daratumumab 18
dectrekumab 13
demcizumab 38
denosumab 9
depatuxizumab 33
depatuxizumab_mafodotin 33
dezamizumab 33
dinutuximab 42
diridavumab 31
domagrozumab 19
drozitumab 27
duligotuzumab 20
durvalumab 18
dusigitumab 36
efalizumab 37
efungumab 32
eldelumab 23
elezanumab 33
elgemtumab 14
elotuzumab 20
emactuzumab 32
emapalumab 32
emibetuzumab 28
enavatuzumab 28
enfortumab_vedotin 16
enoblituzumab 20
enokizumab 34
enoticumab 26
ensituximab 46
eptinezumab 18
erenumab 30
etaracizumab 18
etrolizumab 23
evinacumab 25
evolocumab 31
farletuzumab 7
fasinumab 32
fezakinumab 33
fibatuzumab 25
ficlatuzumab 33
firivumab 37
flanvotumab 30
fletikumab 39
foralumab 19
foravirumab 18
fremanezumab 36
fresolimumab 26
fulranumab 23
futuximab 33
galcanezumab 28
ganitumab 32
gantenerumab 17
gemetuzumab 43
gemtuzumab2 37
gemtuzumab 35
gevokizumab 34
girentuximab 35
glembatumumab 34
glembatumumab_vedotin 34
guselkumab 28
ibalizumab 37
ibritumomab 47
icrucumab 18
idarucizumab 47
ifabotuzumab 25
imalumab 18
imgatuzumab 32
inclacumab 27
indatuximab_ravtansin 35
indusatumab 31
inebilizumab 30
intetumumab 21
iodine_girentuximab 32
ipilimumab 12
iratumumab 29
isatuximab 42
itolizumab 27
ixekizumab 43
labetuzumab_govitecan 28
lambrolizumab 37
lampalizumab 30
lanadelumab 21
landogrozumab 22
laprituximab 36
lebrikizumab 43
lendalizumab 36
lenzilumab 30
lifastuzumab_vedotin 26
ligelizumab 32
lilotomab 44
lirilumab 38
lodelcizumab 30
lokivetmab 28
lorvotuzumab_mertansin 25
lucatumumab 35
lumretuzumab 29
lupartumab 20
lutikizumab 19
margetuximab 36
milatuzumab 45
mirvetuximab 42
mirvetuximab_soravtansin 42
modotuximab 55
mogamulizumab 30
monalizumab 34
motavizumab 40
moxetumomab_pasudotox 26
namilumab 33
naratuximab 42
naratuximab_emtansin 42
narnatumab 23
navicixizumab2 34
navicixizumab 39
navivumab 40
necitumumab 28
nemolizumab 35
nesvacumab 17
nivolumab 21
obiltoxaximab 28
obinutuzumab 39
ocaratuzumab 36
ofatumumab 23
olaratumab 36
olokizumab 25
omalizumab 24
onartuzumab 25
ontuxizumab 39
opicinumab 17
orticumab 17
otelixizumab 40
oxelumab 15
ozanezumab 41
pamrevlumab 15
panobacumab 26
parsatuzumab 33
pasotuxizumab 22
pateclizumab 23
patritumab 31
pembrolizumab 37
perakizumab 26
pidilizumab 24
pinatuzumab_vedotin 22
plozalizumab 27
pogalizumab 35
polatuzumab_vedotin 25
ponezumab 41
prezalumab 17
pritoxaximab 50
quilizumab 22
racotumomab 36
radretumab 20
ralpancizumab 33
ramucirumab 16
ranevetmab 33
ranibizumab 24
refanezumab 30
remtolumab 20
rilotumumab 32
rinucumab 29
risankizumab 39
rituximab 33
rivabazumab 26
robatumumab 22
roledumab 33
romosozumab 32
rontalizumab 28
rosmantuzumab 33
rozanolixizumab 24
sacituzumab 33
sacituzumab_govitecan 33
samalizumab 36
sapelizumab 32
sarilumab 19
secukinumab 22
seribantumab 20
setoxaximab 47
sifalimumab 24
siltuximab 26
simtuzumab 39
sirukumab 17
solanezumab 29
solitomab 35
stamulumab 30
suptavumab 31
suvizumab 26
tabalumab 32
tadocizumab 26
tamtuvetmab 37
tanezumab 35
tarextumab 13
tavolixizumab 25
telisotuzumab 40
teplizumab 27
tesidolumab 37
tezepelumab 37
tigatuzumab 17
tildrakizumab 30
timolumab 19
tisotumab 14
tosatoxumab 42
tositumomab 44
tralokinumab 45
trastuzumab 25
tregalizumab 27
trevogrumab 13
ublituximab 40
urelumab 36
ustekinumab 32
utomilumab 41
vadastuximab 36
vadastuximab_talirin 36
vandortuzumab_vedotin 24
vantictumab 30
vanucizumab2 24
vanucizumab 48
varlilumab 19
vatelizumab 37
vedolizumab 41
veltuzumab 33
vesencumab 15
vorsetuzumab 34
vorsetuzumab_mafodotin 34
vunakizumab 41
xentuzumab 20
zatuximab 55
